Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€87.75

€87.75

1.200%
1.05
1.200%
€90.27
 
10.11.25 / Tradegate WKN: A1H92V / Symbol: C / Name: Citigroup / Stock / Banking Services / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Citigroup Inc. Stock

Citigroup Inc. gained 1.200% today.
The stock is an absolute favorite of our community with 46 Buy predictions and no Sell predictions.
With a target price of 90 € there is a slightly positive potential of 2.56% for Citigroup Inc. compared to the current price of 87.75 €.
So far the community has only identified positive things for Citigroup Inc. stock. The most positive votes were given for criterium "EBIT growth".

Pros and Cons of Citigroup Inc. in the next few years

Pros
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Citigroup Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Citigroup Inc. 1.200% -0.533% 8.481% 37.024% 29.923% 84.698% 117.445%
Comerica Inc. -0.730% 2.985% 5.344% 6.977% 15.966% -6.122% 53.333%
Citizens Financial 0.190% 2.270% 6.766% 5.917% 9.358% 10.993% 62.896%
Regions Financial Corp -0.940% 1.887% -1.818% -10.000% -4.425% -6.087% 67.442%

Comments

Prediction Buy
Perf. (%) 6.53%
Target price 100.831
Change
Ends at 17.10.26

Citigroup (NYSE:C) had its price target raised by analysts at Keefe, Bruyette & Woods from $112.00 to $118.00. They now have an "outperform" rating on the stock.
Ratings data for C provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 1.68%
Target price 103.272
Change
Ends at 15.10.26

Citigroup (NYSE:C) had its price target raised by analysts at Bank of America Corporation from $115.00 to $120.00. They now have a "buy" rating on the stock.
Ratings data for C provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.46%
Target price 115.320
Change
Ends at 15.10.26

Citigroup (NYSE:C) had its price target raised by analysts at Morgan Stanley from $129.00 to $134.00. They now have an "overweight" rating on the stock.
Ratings data for C provided by MarketBeat
Show more

News

Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy: https://g.foolcdn.com/editorial/images/839553/biopharma-research-and-testing.jpg
Citigroup Says This Obesity Drugmaker's Stock Is Now a Buy

Congratulations are (still) in order for pharmaceutical giants Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY). Lilly's Zepbound and Mounjaro along with Novo's Saxenda and Wegovy remain the

What Will Plug Power's Stock Price Be in 1 Year?: https://g.foolcdn.com/editorial/images/839586/gettyimages-945148392-1201x800-5b2df79.jpg
What Will Plug Power's Stock Price Be in 1 Year?

Plug Power (NASDAQ: PLUG) is a controversial stock. According to some of the Wall Street analysts who cover the company, shares could more than double in price over the next year. Others, however

BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?: https://g.foolcdn.com/editorial/images/839655/pensive-invetor-getty.jpg
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher?

Most of 2025 has been disappointing for BioAge Labs (NASDAQ: BIOA) shareholders, but things are looking up. During the week that ended Oct. 25, shares of the obesity drug developer soared by 46.6%.